v3.26.1
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
Jun. 30, 2026
Jun. 30, 2025
Deferred tax assets:    
Net operating loss carryforwards $ 23,674,000 $ 22,222,000
Research and development credit carryforward 27,000 27,000
Capitalized research and development expenses 1,405,000 2,323,000
Stock compensation 68,000 20,000
Disallowed interest expense 879,000 740,000
Lease liability 516,000 322,000
Other, net 1,610,000 2,138,000
Gross deferred tax assets 28,179,000 27,792,000
Less: valuation allowance (27,656,000) (27,508,000)
Total deferred tax assets 523,000 284,000
Deferred tax liabilities:    
Capital lease asset (22,000)
Right of use asset (501,000) (284,000)
Total deferred tax liabilities (523,000) (284,000)
Total net deferred tax liabilities